Analyze Diet
Schweizer Archiv fur Tierheilkunde2019; 161(2); 107-112; doi: 10.17236/sat00197

[Vigilance for veterinary medicinal products: Reports of adverse reactions in the year 2017].

Abstract: A total of 306 reports of adverse reactions to veterinary medicinal products were received during the year 2017 representing an increase of 21% compared to the previous year. The majority of these reports described reactions concerning companion animals (180 dogs and 59 cats) as well as cattle (38 reports) and horses (14 reports). Most of the reported reactions were linked to the use of antiparasitics (158 reports), hormone products (30 reports) and anti-inflammatory products (25 reports). 40 reports were generated from consultations with Tox Info Suisse in Zürich and mainly involved the excessive intake of flavoured tablets and, in some cases, the use of products under the cascade regulation (applied to another species than that authorized). Nine signals were identified from the reports, resulting in revisions of the product information in the sections addressing contra-indications or adverse reactions. Im Jahr 2017 wurden 306 Meldungen zu unerwünschten Wirkungen von Tierarzneimitteln eingereicht, was einer Zunahme von 21% gegenüber dem Vorjahr entspricht. Am häufigsten wurden Reaktionen bei Kleintieren (180 Hunden und 59 Katzen) sowie bei Rindern/Kälbern (38 Meldungen) und Pferden (14 Meldungen) gemeldet. Die am häufigsten betroffenen Medikamentengruppen waren wie in früheren Jahren Antiparasitika (158 Meldungen), Hormonpräparate (30) und Entzündungshemmer (25). Von Tox Info Suisse, Zürich wurden 40 Fälle übermittelt, die mehrheitlich die Aufnahme von Tierarzneimitteln mit Aromastoffen in Überdosis sowie einige Umwidmungen betrafen. Aus den gesammelten Meldungen wurden neun Signale identifiziert, die zur Anpassung der Arzneimittelinformation der betroffenen Präparate in den Rubriken „unerwünschte Wirkungen“ oder „Kontraindikationen“ führten. En 2017, 306 annonces d’effets indésirables de médicaments vétérinaires ont été enregistrées, ce qui constitue une augmentation de 21% par rapport à l’année précédente. Des réactions ont principalement été rapportées chez les petits animaux (180 chiens et 59 chats), ainsi que chez les bovins (38 annonces) et les chevaux (14 annonces). Les groupes de médicaments les plus souvent concernés étaient, comme les années précédentes, les antiparasitaires (158 annonces), les préparations hormonales (30 annonces) et les anti-inflammatoires (25 annonces). Quarante cas ont été transmis par Tox Info Suisse, Zürich, qui concernaient principalement l’absorption en surdose de médicaments vétérinaires aromatisés ainsi que quelques cas de reconversions. Sur la base de l’ensemble des annonces, neuf signaux ont été identifiés qui ont conduit à l’adaptation des informations sur les produits dans les rubriques «effets secondaires indésirables» ou «contre-indications». Nel 2017 sono state inoltrate 306 notifiche di effetti indesiderati di medicamenti per uso veterinario. Questo rappresenta rispetto allo scorso anno un incremento del 21%. Più di frequente sono state inoltrate notifiche relative a reazioni nei piccoli animali (180 cani e 59 gatti), nei bovini e vitelli (38 notifiche) e nei cavalli (14 notifiche).  I gruppi di medicinali maggiormente messi in causa sono gli antiparassitari (158 notifiche), i preparati ormonali (30) e gli antiinfiammatori (25). Dal Tox Info Suisse di Zurigo sono stati trasmessi 40 casi, riguardanti principalmente l’ingestione in sovradosaggio di medicinali ad uso veterinario contenenti aromi e alcuni con un cambiamento di destinazione. Tra tutte le notifiche sono stati identificati 9 punti che hanno portato a un adeguamento delle informazioni del preparato in questione nelle rubriche “effetti indesiderati” oppure “controindicazioni”.
Publication Date: 2019-01-31 PubMed ID: 30696613DOI: 10.17236/sat00197Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article reviews reports of adverse reactions to veterinary medicinal products in 2017, noting an increase of 21% from the previous year. Most cases involved companion animals, with antiparasitics, hormone products, and anti-inflammatory products causing most reactions.

Overview of the research

  • The study examines 306 reports of adverse reactions to veterinary medicinal products in 2017, indicating a 21% increase compared to the reports from the previous year.
  • Among cases reported, most concerned companion animals such as dogs and cats, followed by cattle and horses.

Identification of Contributing Products

  • The majority of adverse reactions reported were related to the use of antiparasitics, hormone products, and anti-inflammatory products.
  • 40 of the reported incidents were triggered due to consultation with Tox Info Suisse in Zürich and predominantly involved excessive intake of flavored tablets and in some cases, misuse of products under the cascade regulation, when they were applied to a different species than intended.

Analysis of Signals and Updates to Product Information

  • Nine signals, or potentially new adverse reactions not documented before, were identified from the collection of reports. These signals prompted revisions in the product information, particularly in areas describing contra-indications or adverse reactions.
  • The identification of these signals played a crucial role in improving the safety information available about the implicated veterinary medicinal products, hence, enabling better understanding and reduction in the occurrence of such adverse reactions.

Cite This Article

APA
Müntener C, Kupper J, Naegeli H, Gassner B. (2019). [Vigilance for veterinary medicinal products: Reports of adverse reactions in the year 2017]. Schweiz Arch Tierheilkd, 161(2), 107-112. https://doi.org/10.17236/sat00197

Publication

ISSN: 0036-7281
NlmUniqueID: 0424247
Country: Switzerland
Language: ger
Volume: 161
Issue: 2
Pages: 107-112

Researcher Affiliations

Müntener, C
  • Institut für Veterinärpharmakologie und -toxikologie, Vetsuisse-Fakultät, Universität Zürich.
  • Swissmedic, Schweizerisches Heilmittelinstitut, Bern.
Kupper, J
  • Institut für Veterinärpharmakologie und -toxikologie, Vetsuisse-Fakultät, Universität Zürich.
  • Tox Info Suisse, Zürich.
Naegeli, H
  • Institut für Veterinärpharmakologie und -toxikologie, Vetsuisse-Fakultät, Universität Zürich.
Gassner, B
  • Swissmedic, Schweizerisches Heilmittelinstitut, Bern.

MeSH Terms

  • Adverse Drug Reaction Reporting Systems / statistics & numerical data
  • Animals
  • Drug-Related Side Effects and Adverse Reactions / epidemiology
  • Drug-Related Side Effects and Adverse Reactions / veterinary
  • Switzerland / epidemiology
  • Veterinary Drugs / adverse effects